Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival

2 Views
administrator
administrator
07/10/23

The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next